The forecast for anti-infective medicine sales in Denmark from 2024 to 2028 indicates a slight, but consistent, decline. The sales value in 2024 is projected at 7.8% of total sales, decreasing marginally to 7.6% by 2028. This trend suggests a year-on-year variation of -1.28% from 2024 to 2025 and stabilizes around -0.67% in the following years. Given that we are in 2024, it's essential to note that the compound annual growth rate (CAGR) over these five years averages around -0.64%, denoting a gradual reduction in market share.
Future trends to watch for include the advancement of drug-resistant strains, which may affect demand for specific anti-infective medicines. Additionally, changes in healthcare policies and the introduction of new, more effective pharmaceuticals could significantly alter these projections.
